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Abstract: Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide with diverse
developmental roles, including differentiation of skeletal elements. It is a positive regulatory factor of
chondrogenesis and osteogenic differentiation in vitro, but little is known about its in vivo role in bone
formation. In our experiments, diaphyses of long bones from hind limbs of PACAP gene-deficient
mice showed changes in thickness and increased staining intensity. Our main goal was to perform a
detailed morphological and molecular biological analysis of femurs from PACAP knockout (KO) and
wild type (WT) mice. Transverse diameter and anterior cortical bone thickness of KO femurs showed
significant alterations with disturbed Ca2+ accumulation and collagen type I expression. Higher
expression and activity of alkaline phosphatase were also observed, accompanied by increased
fragility PACAP KO femurs. Increased expression of the elements of bone morphogenic protein
(BMP) and hedgehog signalling was also observed, and are possibly responsible for the compensation
mechanism accounting for the slight morphological changes. In summary, our results show that lack
of PACAP influences molecular and biomechanical properties of bone matrix, activating various
signalling cascade changes in a compensatory fashion. The increased fragility of PACAP KO femur
further supports the role of endogenous PACAP in in vivo bone formation.
Keywords: hedgehog; BMP; collagen expression; inorganic matrix; alkaline phosphatase activity;
bone fragility
1. Introduction
Molecular mechanisms regulating bone development and regeneration have been intensely
studied over the last two decades, but still there are several signalling pathways with less-understood
functions in these fields [1]. Morphology and stability of long bones determine the size, strength
and motility of animals. Subsequently, the maintenance of a proper inorganic and organic matrix
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composition and turnover is essential for the appropriate biomechanical function of long bones [2].
Matrix production and its composition are crucial factors for adequate limb development and normal
callus formation [3]. Development of long bones or the osteoprogenitor-osteoblastic transformation
is regulated by various signalling mechanisms such as bone morphogenic protein (BMP), hedgehog
(HH) and Wingless int1 (WNT) pathways [1,4]. The initial steps of osteogenesis are followed by the
induction of bone specific matrix production, in which collagen type I is the major organic component.
Orientation and thickness of collagen lamellas together with inorganic components provide the specific
architecture in cortical bone. This lamellar architecture ensures the biomechanical stability and the
tensile strength of compact bone [5]. Besides the production of the organic components of bone matrix,
osteoblasts also take an active part in the calcification of bone matrix. Calcium hydroxyapatite deposits
between the collagen lamellas and intercalation of calcium salt crystals in the periodic gaps of collagen
fibrils provide the hardness of bone tissue [6].
For precise regulation of extracellular matrix (ECM) production, activation of osteoblasts
requires a proper timing and milieu which can be triggered by cytokines, growth hormones or
other endocrine/paracrine pathways [1]. BMP is one of the basic activators of bone development
which can bind to BMPR (bone morphogenic protein receptor) and trigger the phosphorylation of
Smad1/5 followed by its nuclear translocation. This pathway induces the production of various
proteins such as alkaline phosphatase (ALP), osterix or even collagen type I; all are essential to proper
bone formation [7]. Furthermore, it has been demonstrated that BMPs activate the transcription factor
cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB) via the activation
of protein kinase A (PKA) which also triggers the expression of molecules mentioned above [8]. On the
other hand, bone formation is regulated by Runx2 transcription factor which can also be activated by
PKA and it regulates the expression of bone specific molecules and ECM components [9]. At this point
there is a putative link between pituitary adenylate cyclase activating polypeptide (PACAP) signalling
and bone formation, as PKA is its first described and major intracellular mediator [10].
PACAP comprises 38 amino acid residues (PACAP 1-38) and a shorter α-amidated form that
corresponds to the 27 residues of the N-terminus (PACAP 1-27) can also be generated. Its biologically
active region is completely preserved during evolution [11]. The presence of the neuropeptide
has been shown in several peripheral tissues, such as in gonads [12], intestine [13], kidney [14],
or testis [15]. It has been demonstrated that PACAP can prevent the harmful effect of oxidative
stress [16,17], trigger the activation of anti-inflammatory processes and can have a positive role during
ischemic conditions [18]. PACAP is also known to activate the immune system [19] and to induce
tissue regeneration [20]. It plays an important role in the development of different organs, regulates
chondrogenesis and spermatogenesis [16], and influences the development of the central nervous
system [10,21]. Numerous recent experiments have also proven the importance of PACAP in limb
development [16,22,23].
PACAP has three major receptors, vasoactive intestinal polypeptide receptor (VPAC)1, VPAC2
and pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1), the latter one of
which has the highest affinity to the neuropeptide [10]. PAC1 and VPAC1 receptors have been
proven to be expressed on UMR-106 osteoblast cells [24], while VPAC2 was detected in MC3T3E1
calvarial osteogenic cell lines [25]. Release of PACAP from sympathetic nerve endings in bone tissue
has also been demonstrated [26]. In vitro it has a positive effect on calcification and bone matrix
production [16,24]. PAC1 receptor is a G protein coupled receptor, which has several crosstalks
with different signalling pathways [10,22]. Binding of PACAP receptors leads to the induction of
PKA activation, the canonical signalling pathway of PACAP signalization. PKA can subsequently
activate several transcription factors such as CREB, Runx2 or Sox9 [16,22,24]. The activation of PACAP
receptors may form a signalization crosstalk with BMP, WNT or β-catenin pathways or have a negative
regulatory connection with the Sonic Hedgehog (SHH) signalization [27]. Ca2+ dependent pathways
can be activated via PAC1 receptors and intracellular Ca2+ release has been detected in the presence of
PACAP [28].
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The importance of PACAP and its signalization has been proven in several tissues, but we do
not have a clear picture about its role in long bone development. In this study we demonstrate the
importance of PACAP in the regulation of matrix production in long bones. Furthermore, we analyzed
the possible signalling crosstalk in wild type (WT) and PACAP KO mice, possibly modifying the
biomechanical stability of cortical bone.
2. Results
2.1. Bone Morphology Is Only Slightly Modified in PACAP Gene Deficient Mice
First, anatomical alterations were investigated in hind limbs of PACAP gene-deficient mice.
Interestingly hind limb bone morphology of PACAP KO mice was not significantly altered.
No differences were detected in the length of femur or tibia, and no other anatomical alterations
were visible (Figures 1A and S3). No difference was found in the length of tibia with CT (computed
tomography) analysis. Femur length of PACAP KO mice was tendentiously shorter but did not reach
a significant level (Figure S2A,B). Randomly increased alizarin red intensity was detected as it is
visible at the tip of arrows in Figure 1A. However, some thinner parts also appeared in the femur
diaphyses of gene deficient mice (Figure 1A), but the optical density of the stained bone had no
significant alterations in PACAP KO animals (Figures 1A and S3). Therefore, further analysis was
performed focusing on femurs. In cross sections of the diaphyses, the cortical part was thicker in
PACAP KO animals than in WTs with hematoxilin-eosin (HE) staining (Figure 1B). The diameter of
bone marrow cavities was wider in WT animals (Figure 1B) in sections from the same level. A CT
analysis was performed to quantify the exact differences of cortical bone thickness and internal cavity.
The proximal and distal epiphyses did not show any significant morphological differences, therefore
only the diaphyses were further analyzed. Femur lengths were not significantly altered in PACAP
KO mice (Figure S2A). Similarly, no significant differences were found in the posterior cortical area
or in the sagittal diameters (Figure 1D). On the contrary, the anterior cortical bone was significantly
thicker in the gene deficient animals (Figure 1C). Although the sagittal diameter of the diaphyses
had no significant alterations, the transverse diameters were significantly shorter in PACAP KO mice
(Figure 1E,F). Further analysis of the CT results did not show any other significant alterations, only the
density of the femur at the level of greater trochanter was tendentiously lower in PACAP KO animals
(Figure 1G), suggesting certain alterations in the bone matrix of KO animals.
2.2. Inorganic Matrix Production Is Disturbed in PACAP KO Mice
In further steps, the inorganic matrix component of femur diaphyses was investigated in detail.
To visualize the Ca2+ content of bone ECM von Kossa and alizarin red stainings were performed.
A remarkable inhomogeneity in Ca2+-phosphate content of the diaphyses in certain parts of the KO
femurs was observed (Figure 2A). The femurs contained more Ca2+ phosphate closer to the distal
end of the diaphyses, while the proximal parts had reduced Ca2+ content in KO compared with
WT mice (Figures 2A and S4A). Although these differences were visible with alizarin red staining,
the whole femur did not have any macroscopical disorders. In order to explore the possible background
molecular mechanisms, expression levels of enzymes responsible for matrix production in bone were
followed with molecular biological methods. mRNA expression was altered (Figures 2C and S4B) and
protein expressions of alkaline phosphatase (ALP) and its target molecule, osterix, were significantly
elevated in PACAP deficient animals (Figures 2D and S4C). Moreover, other matrix molecules, such as
osteocalcin and osteopontin, which can be related to the altered inorganic bone matrix deposition,
showed increased expression in KO mice (Figures 2D and S4C). Their mRNA expression did not show
alterations (Figures 2C and S4B). As protein expression is not always in direct relation with the enzyme
activity, ALP activity was also assayed and a dramatic increase was detected in femur samples of
PACAP KO mice (Figure 2E).
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Figure 1. Morphological analysis of hind limbs of wild type (WT) and pituitary adenylate cyclase 
activating polypeptide (PACAP) knockout (KO) mice. Whole limb alizarin red staining (A), optical 
density (OD) was determined in 1 cm distal part of the femur. Hematoxilin-eosin (HE) staining (B) to 
visualize the histological differences. Original magnification was 4×. Scale bar, 500 µm. CT analysis 
(C–G) of mouse femurs. Representative data of 5 independent experiments. Asterisks indicate 
significant (* p < 0.05) difference in thickness of cortical bone or in the diameter of diaphysis compared 
to the respective control. 
Figure 1. Morphological analysis of hind limbs of wild type (WT) and pituitary adenylate cyclase
activating polypeptide (PACAP) knockout (KO) mice. Whole limb alizarin red staining (A), optical
density (OD) was determined in 1 cm distal part of the femur. Hematoxilin-eosin (HE) staining (B) to
visualize the histological differences. Original magnification was 4×. Scale bar, 500 µm. CT analysis
(C–G) of mouse femurs. Representative data of 5 independent experiments. Asterisks indicate
significant (* p < 0.05) difference in thickness of cortical bone or in the diameter of diaphysis compared
to the respective control.
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Fig re 2. Investigation of inorganic matrix production of long bones. von Kossa (A) and alizarin red (B)
staining of cryosectioned samples. Original mag ificatio was 4×. Scale bar: 500 µm. Optical density
(OD) was determined in microphotographs and normalised to wild type samples. mRNA (C) and
protein (D) expression of alkaline phosphatase (ALP), osterix, osteocalcin and osteopontin of femurs.
For reverse transcription followed by polymerase chain reaction (RT-PCR) and Western blot reactions,
actin was used as control. Optical signal density was measured and results were normalised to the
controls. For panels (C,D) numbers below signals represent integrated signal densities determined by
ImageJ software. (E) ALP activity in compact bone. Asterisks indicate significant (* p < 0.05) alteration
of ALP activity compared to the respective control. Representative data of 3 independent experiments.
2.3. Augmented Collagen Type I Expression in PACAP KO Mice
Morphology of the femur was not altered in spite of the elevated inorganic bone matrix production,
therefore, further analysis of organic matrix production was performed. Orientation of collagen type
I-made fibers in a cortical lamella is a crucial factor in determining the microscopical structure and
macroscopic morphology of compact bone. Therefore, this organic component of compact bone was
further investigated. Concentric lamellae of compact bone were found thicker in PACAP gene deficient
mice shown with picrosirius red staining in polarization microscope (Figure 3A). Collagen fibers in
WT animals were present, although they seemed to be thinner (Figures 3A and S5A). Furthermore,
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the immunohistochemical analysis verified the previous results (Figures 3B and S5B): concentric
collagen lamellas were visualised in both experimental groups with stronger signals of PACAP KO
mice (Figure 3B). Immunopositivity around the osteocytes had no significant differences between
WT and KO mice (Figures 3B and S5B). To detect the total expression of collagen type I, reverse
transcription followed by polymerase chain reaction (RT-PCR) and Western blot were performed.
mRNA expression of the major organic extracellular matrix component was elevated in PACAP gene
deficient animals (Figures 3C and S5C), and a dramatically increased protein expression was also
observed (Figures 3D and S5D).
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Figure 3.Collagen type I expression in femurs. (A) Collagen expression of cortical bone was visualized 
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Figure 3. Collagen type I expression in femurs. (A) Collagen expression of cortical bone was visualized
with picrosirius staining, and photomicrographs were made by polarization microscope. Original
magnification was 20×. Scale bar: 200 µm. Numbers below the photos show the differences of
concentric lamellas thickness. (B) Immunohistochemistry of collagen type I in cortical bones. Original
magnification was 20×. Scale bar: 200 µm. mRNA (C) and protein (D) expression of collagen type
I. For RT-PCR and Western blot reactions, actin was used as controls. Optical signal density was
measured and results were normalised to the controls. For panels (C,D) numbers below signals
represent integrated signal densities determined by ImageJ software. Asterisks indicate significant
(* p <0.05) alteration of expression compared to the respective controls. Representative data of
3 independent experiments.
2.4. Alterations of PACAP Signalling Pathway in Cortical Bone
As PACAP can act on three different receptors, we monitored mRNA and protein expressions
of PAC1, VPAC1 and VPAC2 receptors. We were not able to detect the mRNA of VPAC1 receptor
in cortical bone (Figure 4A). PAC1 receptor was expressed equally in PACAP KO and WT mice,
while the protein expression of VPAC2 was elevated in gene deficient animals (Figures 4A,B and
S6A,B). The major downstream target of PACAP signalization is PKA, which was detected in both
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genotypes without significant differences in its expression (Figures 4A,B and S6A,B). The most
important transcription factors that are substrates of PKA, are CREB and Runx2 in bone development.
Phosphorylation of CREB is regulated by PKA and a reduced amount of phospho-CREB was detected
in PACAP KO mice, while mRNA expression of CREB was detected without alteration and the
unphosphorylated protein of CREB was not altered significantly (Figures 4A,B and S6A,B). Surprisingly,
the mRNA and protein expression of Runx2 transcription factor was increased in bone samples of
PACAP deficient mice (Figures 4A,B and S6A,B). Moreover, a much higher level of nuclear Runx2 was
detected in osteocytes of KO femurs (Figure 4C, Figure S6C).
Int. J. Mol. Sci. 2018, 19, x 7 of 22 
 
magnification was 20×. Scale bar: 200 µm. Numbers below the photos show the differences of 
concentric lamellas thickness. (B) Immunohistochemistry of collagen type I in cortical bones. Original 
magnification was 20×. Scale bar: 200 µm. mRNA (C) and protein (D) expression of collagen type I. 
For RT-PCR and Western blot reactions, actin was used as controls. Optical signal density was 
measured and results were normalised to the controls. For panels (C) and (D) numbers below signals 
represent integrated signal densities determined by ImageJ software. Asterisks indicate significant (* 
p <0.05) alteration of expression compared to the respective controls. Representative data of 3 
independent experiments. 
2.4. Alterations of PACAP Signalling Pathway in Cortical Bone 
As PACAP can act on three different receptors, we monitored mRNA and protein expressions 
of PAC1, VPAC1 and VPAC2 receptors. We were not able to detect the mRNA of VPAC1 receptor in 
cortical bone (Figure 4A). PAC1 receptor was expressed equally in PACAP KO and WT mice, while 
the protein expression of VPAC2 was elevated in gene deficient animals (Figure 4A,B, Figure S6A,B). 
The major downstream target of PACAP signalization is PKA, which was detected in both genotypes 
without significant differences in its expression (Figure 4A,B, Figure S6A,B). The most important 
transcription factors that are substrates of PKA, are CREB and Runx2 in bone development. 
Phosphorylation of CREB is regulated by PKA and a reduced amount of phospho-CREB was detected 
in PACAP KO mice, while mRNA expression of CREB was detected without alteration and the 
unphosphorylated protein of CREB was not altered significantly (Figure 4A,B, Figure S6A,B). 
Surprisingly, the mRNA and protein expression of Runx2 transcription factor was increased in bone 
samples of PACAP deficient mice (Figure 4A,B, Figure S6A,B). Moreover, a much higher level of 
nuclear Runx2 was detected in osteocytes of KO femurs (Figure 4C, Figure S6C). 
 
Figure 4. PACAP signalisation in bones. (A) mRNA and (B) protein expression of pituitary adenylate 
cyclase-activating polypeptide type I receptor (PAC1), vasoactive intestinal polypeptide receptor 
(VPAC)1, VPAC2,protein kinase A (PKA), cyclic adenosine monophosphate (cAMP) response 
element-binding protein (CREB), Runx2 in cortical bone. Actin was used as a control. Numbers below 
signals represent integrated signal densities determined by ImageJ software. Asterisks indicate 
significant (* p < 0.05) alteration of expression compared to the respective controls. Representative 
4. PACAP signalisation in bones. (A) mRNA and (B) protein expression of pituit ry
adenylate cyclase-activating pol ptide type I receptor (PAC1), vasoac ve intestinal polypeptide
receptor (VPAC)1, VPAC2,protein kinase A (PKA), cyclic adenosine m nophosphate (cAMP) r
l t- i i g protein (CREB), Runx2 in cortical bone. Actin was used as a control. Numbers
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data of 3 independent experiments. (C) Immunohistochemistry of Runx2 in cortical bones. Original
magnification was 60×. Scale bar: 5 µm. Representative data of 3 independent experiments.
2.5. Alterations of Possible Signalling Crosstalks
One of the major regulators of bone development is the BMP signalling cascade. Therefore,
we investigated the ligands of BMPR1, which is known to play a crucial role in limb development [4].
No alterations were detected in the mRNA or protein expressions of BMP2 (Figures 5A,B and S7A,B).
Similarly, BMP4 protein expression had no difference between the two different genotypes, although
BMP4 mRNA expression was tendentiously elevated in KO animals (Figures 5A and S7A,B). BMPs,
such as BMP6 and BMP7, playing fundamental roles in cortical bone formation, showed increased
mRNA and significant protein expression elevation in PACAP KO mice (Figures 5A,B and S7A,B).
Furthermore, BMPR1, the receptor of these BMPs showed higher mRNA and protein expression in the
PACAP KO animals than in WT mice (Figures 5A,B and S7A,B). Activation of BMP signalling can be
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judged by its downstream targets, such as Smad transcription factors. Although mRNA expression of
Smad1 was tendentiously reduced in gene deficient mice (Figures 5A and S7A), the protein expression
was significantly elevated, almost doubled in the same samples (Figures 5B and S7B). Smad1 nuclear
localization is a sign of its activation, therefore, immunohistochemistry was performed. In the cortical
bone of PACAP KO mice the nuclear localization of Smad1 was stronger in confocal series than in WT
littermates (Figures 5C and S7C).
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Figure 5. Si nallin co nections of PAC1 rece t r. RNA (A,D) and protein (B,E) expression of bone
morphogenic protein (BMP)2, BMP4, BMP6, BMP7, BMPR1, Smad1, Indian Hedgehog (IHH), Sonic
Hedgehog (SHH), Patched (PTCH)1 and Gli1 in cortical bone. For RT-PCR and Western blot reactions,
actin was used as controls. Signals optical density was measured and results were normalised to the
optical density of controls. For panels (A,D) and (B,E) numbers below signals eprese t integrated
densities of signals determined by ImageJ software. (C) Smad1 immunohistochemistry in bones.
Original magnification was 60×. Scale bar: 5 µm. (F) Three point bending tests of long bones. (a) Value
of the loading force at crack (Fm), and (b) the value of the bending deformation at crack (∆lm) were
demonstrated. Asterisks indicate significant (* p < 0.05) alteration of expression as compared to the
respective control. Representative results of 3 independent experiments.
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PACAP activation exerts an inhibitory effect on hedgehog signalling, which in turn influences
extracellular matrix production and BMP expression. We monitored the molecular components
contributing in the canonical way of hedgehog signalization. Both the mRNA and protein expression
of Indian Hedgehog (IHH) and SHH increased in PACAP gene deficient bones (Figures 5D,E and
S7A,B). Likewise, the main receptor of these ligands, Patched (PTCH)1 also increased in the PACAP
KO animals (Figures 5D,E and S7A,B), and mRNA and protein expression of Gli1, the downstream
target of the receptor activation, was elevated in gene-modified tissues (Figures 5D,E and S7A,B).
2.6. Biomechanical Properties of Bones Are Altered in PACAP KO Mice
As we observed significantly altered BMP and HH signalization and imbalanced bone matrix
composition in bone samples of PACAP KO mice without any obvious macroscopic morphological
changes, we hypothesized that the bone tissue in KO femurs may have worse biomechanical properties
compared to WT samples. Therefore, we performed bone fracture assays and measured two parameters.
The force needed for a complete fracture at shafts of PACAP KO femur was significantly lower than
in WT mice (Figure 5(Fa)). Reflection of the femur shafts had no significant differences between the
two genotypes, although the bones from PACAP deficient mice had tendentiously higher inclination
(Figure 5(Fb)).
3. Discussion
PACAP is a neuropeptide with important roles in several differentiation processes in the central
nervous system and also in the periphery [10,29,30]. Our laboratory has already proven its importance
during in vitro cartilage differentiation and we have also demonstrated its preventative function
during oxidative stress [16] and mechanical load in chondrogenesis [27]. Presence of PACAP positive
sympathetic fibers was detected in the epiphysial cartilage canals of pigs and as a neurohormone it
can also reach bones via vessels [26]. In vitro studies have proven the presence of PACAP receptors
in MC3T3E1 [25] and UMR 106 osteoblastic cell lines [24]. Although PACAP gene deficient mice do
not have marked visible morphological alterations, their behavior and movement activity is slightly
changed compared with the wild type animals [31].
In our experiments, we found only minor macroscopic differences in bone shape and size but the
detailed CT analyses showed an increase of anterior cortical bone thickness and elevation of transverse
diameter in the femur shafts in KO mice. The density of femur trochanter did not show significant
alterations but it was tendentiously lower in PACAP gene deficient mice. As significant changes were
detected mostly in the femur, therefore our main experiments were focused on this bone. Disorders of
femur signalling pathways result in an alteration of bone microarchitecture, subsequently, fracture
characteristics and mechanical load bearing of long bones may decrease [32,33].
To investigate the molecular mechanisms in the background of cortical bone histological
alterations, we focused on the signalling pathway of PACAP and putative signaling crosstalks.
It has been demonstrated that the lack of Gα protein reduces bone mass in mice [34]. As PAC1
receptor is a G protein coupled receptor, its inactivation may be involved in the generation of an
altered bone architecture. Since significant morphological changes were not visible at KO femurs,
we hypothesized that the lack of PACAP signalling induced activation of unusual crosstalk of certain
signalling molecules or evoked compensatory molecular mechanisms. PAC1 receptor was detected in
WT and PACAP KO mice equally but the expression of its downstream elements was altered. Activation
of PACAP receptors induces the elevation of intracellular cAMP concentration, subsequently triggering
elevated activation of PKA, which is considered the classical downstream mechanism of PACAP
signaling [10]. PKA can phosphorylate several transcription factors in skeletal tissue development,
such as CREB, Sox9 [35,36] or Runx2 [24]. The nuclear translocation of these factors induces the
activation of genes encoding extracellular matrix component proteins. The expression of PKA and
CREB did not significantly change, but the more active, phosphorylated form of CREB decreased in
gene deficient mice. Activation/phosphorylation of CREB is required for proper bone formation [37],
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but there are other transcription factors which can also be influenced by PKA signalling pathway
and contribute to the regulation of osteogenesis. Runx2 can be activated via PACAP-PKA axis [24],
which was increased in PACAP KO mice. This may suggest a PACAP dependent and independent
activation of this transcription factor which may compensate the lack of CREB activation. On the other
hand, Runx2 via the IHH activation also plays a role in ossification [38]. Both CREB and Runx2 can
regulate the expression of collagenous and non-collagenous proteins building organic bone matrix and
influencing deposition of inorganic components of compact bone (Figure 6).
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Figure 6. Schematic drawing of the possible signalling pathways regulated by PACAP in bone
formation. PAC1 receptor activation leads to the increase of intracellular cAMP, which activates
PKA. Downstream targets of PKA can be CREB or Runx2 transcription factors which activations induce
the expression of collagen type I, osterix, osteocalcin, ostepontin and ALP. BMP6 and BMP7 binding to
BMPR1 triggers the activation of Smad cascade which can induce the expression of collagen type I,
osterix, osteocalcin, ostepontin, ALP and IHH. The activation of BMP signalling is fine-tuned by the
activation of PACAP signalling. Runx2 phosphorylation can occur via BMPR1 activation, showing a
PACAP independent mechanism. IHH and SHH activate Gli1 transcription factor which is inhibited
by PACAP signalling. This signalling pathway is also responsible for the activation of collagen type I
and ALP expression. Increased ALP expression and activation elevates the Ca2+ phosphate production.
PACAP signalling keeps a balance between BMP and hedgehog signalling activation via this regulates
proper bone formation.
First the inorganic component of the extracellular matrix of femur shafts was investigated in
detail. We found focal and regional heterogeneity in the staining intensity of Ca2+ positive matrix
areas in femur diaphyses of PACAP KO mice. These findings suggested disturbed ossification and
local architectural disorders of cortical bone, which may result in altered biomechanical properties of
the femurs of PACAP gene deficient animals [39]. In line with these findings, we reported structural
changes in hard tissues of the teeth of PACAP KO mice [40]. Another finding supporting disturbed
bone mineralisation was the significantly elevated protein expression and activity of ALP in cortical
bone tissue samples of PACAP KO femurs. Expression of bone matrix non-collagenous proteins such as
osterix and osteocalcin, which play a substantial role in inorganic matrix binding to the organic matrix,
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was also found elevated in the same samples. Bone specific ALP is one of the most important signalling
elements which can determine the matrix composition of cortical bone [41]. Although we did not
investigate the tissue distribution of these proteins, but heterogeneity in the staining intensity of the
calcified matrix suggests that the above bone matrix proteins are probably not equally distributed in
the cortical bone of femurs, resulting in focal matrix deposition disorders. Similar phenomena appear
during aging or mechanical loading in bone matrix production [42]. Induction of the transcription of
ALP gene can occur via Runx2 [43], and we observed that expression and nuclear localization of this
transcription factor was significantly higher in gene deficient mice.
Subsequently, ALP activation can affect collagen secretion by osteocytes and osteoblasts [41].
In gene-deficient mice we detected an elevated collagen type I expression and altered lamellar structure
in compact bone. The increased accumulation of collagen type I can be a good marker of biomechanical
characteristics of long bones [44]. Collagen type I has special spiral orientation in cortical bone lamellae.
Alterations in collagen fiber orientation in lamellae may have an effect on strength of bone or on callus
formation which strongly influences bone stability and biomechanical properties [6]. In chronic arthritis
the expression and remodelling of collagen type I is altered, which results in an increased fragility of
bones [45]. Taken together, the proper orientation and expression level of collagen type I is essential
for the stability of long bones. Indeed, when we investigated whether these alterations in bone matrix
production had any negative effect on biomechanical properties of shafts of KO femurs we found that
significantly lower force was needed for bone fracture examining KO bones.
As both the organic and inorganic components of bones were altered without major morphological
disorders, some compensatory changes in the activity of various regulatory mechanisms are supposed,
which are physiologically influenced by PACAP signalling. We have shown a PACAP induced Runx2
nuclear accumulation in UMR-106 cell line [24]. PACAP deficient mice also showed an elevated
nuclear presence of Runx2, which suggests a PACAP independent activation (Figure 6). It is known
that osteogenic differentiation can be regulated by BMP/Runx2/osterix axis as BMP2 can activate
Runx2, which in turn can regulate osterix expression [9]. PACAP signalisation exerts effects on several,
putatively crosstalking downstream signalling pathways, such as WNT, β-catenin, hedgehog and
BMP [22,27]. First, we focused on BMP signalling and found elevated mRNA expression of BMP4,
6 and 7, while protein levels only of BMP6 and 7 were higher in PACAP KO mice. No alterations were
shown in either the mRNA or protein expression of BMP2. BMP7 and BMP2 have a direct connection
with the activation of Runx2 expression [9,46,47], but their action exhibits differences [48]. BMP7
can directly induce the expression of Runx2 but does not regulate the matrix production similarly to
BMP2 [48]. It was reported that BMP7 addition increased the activity of ALP in MC3T3 cultures [49].
This observation may imply that inhibition of PACAP receptors has direct connection with BMP7
expression. On the other hand BMP6, the most potent among the BMPs, regulates the osteogenic
differentiation and its elevated expression increased the expression of ALP, osterix, osteocalcin and
osteopontin [50]. We have already demonstrated that mechanical load of chondrifying cell cultures
had a direct connection with PACAP signalling [22]. It induced the expression of collagen type X,
a characteristic collagen synthesized by hypertrophic chondrocytes during calcification of cartilage
matrix, preceding ossification or establishing the interface of articular cartilage and subchondral
bone [27]. It is also known that expression of BMP6 and BMP7 is upregulated during mechanical load in
subchondral bone [51]. Our results suggest that BMP6 and BMP7 have partly escaped from the control
or fine tuning effects of PACAP signalling pathway and induced the nuclear translocation of Smad1
transcription factor (Figure 6). This pathway also has an influence on ALP activity, which became
probably randomly over-activated and generated focal enhancement of mineralization (Figure 6).
If these changes occurred without modulation of the activity of any compensatory mechanisms,
abnormal bone development and bone morphological disorders would be expected. Nonetheless,
the macroscopical characteristics of KO femurs showed only minor alterations. Therefore, it is
suggested that BMP over-activation triggers or becomes balanced by another compensatory signalling
mechanism. One of these compensatory mechanisms can be the hedgehog signalling, which has a
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direct connection with PACAP signalisation [27] and also has connection with BMP activation [52].
The activation of PKA induces inhibition of SHH signalling [53], so the absence of PACAP reduces
PKA activation, which in turn triggers the over-activation of SHH signalling. The elevated BMP6 and
BMP7 expressions in PACAP KO mice may have a direct contact with SHH activation, inducing an
approximately normal bone differentiation and formation (Figure 6). Additionally, the expression of
IHH was also increased in PACAP KO mice, and it can also be activated by BMPs [54].The expression
of IHH can be regulated by BMPs [55] and induces the activation of long bone development. Moreover,
Runx2 can have a direct communication with IHH [38]. In chondrogenic cultures we have also shown
that the addition of PACAP decreased while mechanical load elevated the expression of IHH [27].
Subsequently, the increased IHH expression may be responsible for compensatory mechanisms,
suggesting that PACAP has a negative correlation with IHH activation (Figure 6). Adding together
SHH and IHH elevation triggers the action of Gli1, which results in an active bone differentiation
process (Figure 6).
In summary, we can conclude that PACAP signalisation is active during long bone development.
Moreover, its activation has an important function in the fine tuning of crosstalk between several
signalling pathways which are responsible for the formation of anatomically correct femur morphology.
These signalling connections keep the appropriate balance of proper secretion of organic and inorganic
components, which ensure the mechanical properties of long bones. Therefore, disturbance of PACAP
expression implies an altered fragility of cortical bone tissue which may also indicate its possible
importance in various bone formation disorders.
4. Materials and Methods
4.1. Animals
Generation and maintenance of the PACAP-deficient mice on the CD1 background has been
described in detail [56,57]. They were backcrossed at least for ten generations with the CD1 strain.
Genotype was tested with PCR reactions. For the experiments we sacrificed1-month-old wild-type
(WT, n = 18, n = 10 male, n = 8 female) and homozygous PACAP-deficient (PACAP KO, n = 18, n =
10 male, n = 8 female) mice. Animals were fed and watered ad libitum, under light/dark cycles of
12/12 h. All procedures were performed in accordance with the ethical guidelines approved (2 January
2012) by the University of Pécs (permission number: BA02/2000-24/2011).
4.2. Whole Limb Alizarin Staining
Hind limbs were removed and only the skin was peeled off. The entire limb was washed in PBS
three times and fixed in a 4:1 mixture of absolute ethanol and 40% formaldehyde. After washing
in alcohol limbs were incubated in 30, 60 and 80 mM KOH solution for 3 days, 2 days and 1 day,
respectively, till the tissues became completely glossy. Residual KOH was removed by washing in PBS
three times and samples were stained with alizarin red (Sigma-Aldrich, Saint Louis, MO, USA) for
15 min. Limbs were washed in the concentrated glycerine to remove unbound staining. Photos were
made by an Olympus camera, scale was used to demonstrate size differences of hind limbs. Optical
density of 1 cm of distal part of femurs was measured by using ImageJ 1.40g freeware and results were
normalised to the optical density of wild type samples.
4.3. Staining Procedure of Calcificated Tissue
Femurs were dissected and additional tissues were removed. Samples were immediately fixed
in 4% paraformaldehyde dissolved in 0.1 M phosphate buffer (PB) for 24 h at room temperature.
Tissue was then washed in 0.1 MPB, and cryoprotected in 10% sucrose for 1 h, 20% sucrose in
phosphate-buffered saline (PBS) overnight at 4 ◦C. For cryostat sectioning, the bones were embedded in
tissue freezing medium (Tissue-Tek, OCT Compound, Sakura Finetech, Zoeterwade, The Netherlands),
cut in a cryostat (Leica, Nussloch, Germany) using a blade for hard tissues. 20–30 serial sections
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were made from each femur. Sections were mounted on chrome–alum–gelatin-coated subbed slides.
Samples were washed three times in PBS and stained with alizarin red (Sigma-Aldrich) for 5 min
to evaluate calcium-rich deposits. Calcium phosphate deposition as sign of biomineralization was
followed with von Kossa method (Millipore, Billerica, MA, USA). After washing in PBS, samples were
incubated in 1% AgNO3 solution for 40 min. Slides were removed and exposed to UV for 10 min.
Nitrate solution was removed with washing in PBS three times followed by incubation in 5% Na2S2O3
solution for 10 min. Slides were covered with gum arabic. Photomicrographs were taken using
an Olympus DP72 camera on a Nikon Eclipse E800 microscope (Nikon Corporation, Tokyo, Japan).
Optical density of photos was measured by using ImageJ 1.40g freeware and results were normalised
to the optical density of wild type bone.
4.4. Staining Procedure of Decalcified Samples
Femurs were dissected and additional tissues were removed as previously described, washed
in PBS three times and fixed in a 4:1 mixture of absolute ethanol and 40% formaldehyde. Bones
were decalcified in 4% ethylene diamine tetra-acetic acid (EDTA) for four weeks till bones became
soft. Then samples were dehydrated in ascending alcohol row and embedded in paraffin. 5 µm of
serial sections were made. After rehydration, hematoxilin eosin (Sigma-Aldrich) and picrosirius red
(Sigma-Aldrich) stainings were performed. All of the staining protocols were carried out according to
the instructions of manufacturer. Photomicrographs were taken using an Olympus DP72 camera on
a Nikon Eclipse E800 microscope (Nikon Corporation). Picrosirius staining was analyzed with the
polarization module of Nikon Eclipse E800 microscope. Thickness of lamellas was measured by using
ImageJ 1.40g freeware. In 3 independent experiments 10 lamellas diameter were calculated and given
in pixel unit. Results of wild type animals were compared with gene deficient mice where differences
were given in percentage.
4.5. Radiographic Analysis (Micro-CT Scan)
Bruker SkyScan 1176 Micro CT Scanner is an X-ray computed tomography system for non
invasive imaging of bone morphological parameters. CT scanner was calibrated 50 kV, 500 µA pitch.
Reconstruction of the slides was performed by NRecon (1.6.10.4 version) and CTAn (1.15.4.0 version)
(Bruker MicroCT, Kontich, Belgium) was used to evaluate them. Femur CT studies obtained by using
this micro-CT. Radiographs were used to analyze femur cortical thickness in ventral and dorsal aspects
and femur densitometry of PACAP KO and WT mice was also performed. Density was measured in
the region of greater trochanter. Using general anesthesia with 1% Euthasol (0.7 µL/10 g) the total
femur length (mm) from the greater trochanter to the medial condyle was measured in 18 KO and
18 WT mice.
4.6. Measurement of Alkaline Phosphatase Activity
After dissection of hind limbs, femur diaphysis was removed and opened to remove bone marrow
from the sample. Cortical bone was washed in PBS three times and 100 µL Radio Immuno Precipitation
Assay (RIPA)-buffer (150 mM sodium chloride; 1.0% NP40, 0.5% sodium deoxycholate; 50 mM
Tris, pH 8.0) containing protease inhibitors (Aprotinin (10 µg/mL), 5 mMBenzamidine, Leupeptin
(10 µg/mL), Trypsine inhibitor (10 µg/mL), 1 mM PMSF, 5 mM EDTA, 1 mM EGTA, 8 mM Na-Fluoride,
1 mM Na-orthovanadate) was added to each experimental group. Bone tissues were mechanically
ground in liquid nitrogen (Cryo-Grinder, Nanotestkft., Budapest, Hungary) and sonicated by pulsing
burst for 30 s at 40 A (Cole-Parmer, IL, USA). Protein concentration of samples was measured and
equalized with BCA-protein assay (Pierce™, Rockford, MA, USA). ALP activity measurement was
performed according the protocol of manufacturer. Results were measured on 420 nm (Chameleon,
Hidex Ltd., Turku, Finland). Activity of ALP was calculated according to the manufacturer’s protocol.
Five independent measurements were used to demonstrate significant differences.
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4.7. Immunohistochemistry
Femurs were dissected and additional tissues were removed. Briefly, bones were washed in PBS
three times and fixed in Saint-Marie’s fixative (99% ethanol and 1% anhydrous acetic acid) for 24 h.
The bones were decalcified in 4% EDTA for four weeks until the bones became soft. Then samples
were dehydrated in descending alcohol row and embedded in paraffin. 5 µm serial sections were
made. Sections were rehydrated in ascending alcohol row and washed in PBST (phosphate buffered
saline supplemented with 1% Tween-20) three times. Nonspecific binding sites were blocked in PBST
supplemented with 1% bovine serum albumin (BSA, Amresco LLC, Solon, OH, USA) at 37 ◦C for
30 min.
For collagen type I, Smad1 and Runx2 immunohistochemistry sections were incubated in
anti-Collagen type I. (Sigma-Aldrich) at a dilution of 1:500, in anti-Smad1 (Cell Signaling, Danvers, MA,
USA) at a dilution of 1:600, and anti-Runx2 (Cell Signaling, Danvers, MA, USA) at a dilution of 1:600
at 4◦C overnight. Primary antibodies were visualised with anti-rabbit Alexa555 and/or anti-mouse
Alexa488 secondary antibodies (Life Technologies Corporation, Carlsbad, CA, USA) at a dilution
of 1:1000. Slides were mounted in Vectashield Hard Set mounting medium (Vector Laboratories,
Peterborough, UK) containing DAPI to visualise the cell nuclei. Photomicrographs of collagen
type I were taken using an Olympus DP72 camera on a Nikon Eclipse E800 microscope (Nikon
Corporation, Tokyo, Japan). Images were acquired using cellSense Entry 1.5 software (Olympus,
Shinjuku, Tokyo, Japan) with constant camera settings to allow comparison of fluorescent signal
intensities. For investigation of subcellular localization of Smad1 and Runx2 fluorescent images were
taken with an Olympus FV1000S confocal microscope (Olympus Co., Tokyo, Japan) using 40× oil
immersion objective (NA: 1.3). For excitation, laser lines of 543 nm and 488 nm were used. The average
pixel time was 4 µs. Z image series of 1 µm optical thickness were recorded in sequential scan mode.
Images of Alexa555 and DAPI were overlaid using Adobe Photoshop version 10.0 software.
4.8. RT-PCR Analysis
In liquid nitrogen femurs were cryo-ground and collected in TriReagent (Applied Biosystems,
Foster City, CA, USA). 20% RNase free chloroform was added to the dissolved samples and followed
by a centrifugation at 4 ◦C at 10,000×g for 15 min. Samples were incubated in 500 µL of RNase-free
isopropanol at −20 ◦C for 1 h then total RNA was harvested in RNase free water and stored at
−20 ◦C. For reverse transcriptase reaction the assays contained 2 µg RNA, 0.112 µM oligo(dT), 0.5 mM
deoxynucleotide triphosphate (dNTP), 200 units of High Capacity RT (Applied Bio-Systems, Waltham,
MA, USA) in 1× RT buffer and RT reaction was run in a thermal cycler (Labnet MultiGene™ 96-well
Gradient Thermal Cycler; Labnet International, Edison, NJ, USA). Sequences of primer pairs, amplimer
sizes and further details are given in Table 1. Amplifications were performed in a thermal cycler (Labnet
MultiGene™ 96-well Gradient Thermal Cycler; Labnet International). Final volume of assay mixture
was 21 µL (containing 1 µL forward and reverse primers [0.4 µM], 0.5 µL dNTP [200 µM], and 5 units
of Promega GoTaq® DNA polymerase in 1× reaction buffer) and protocols were set as follows: 95 ◦C,
2 min, followed by 35 cycles (denaturation, 94 ◦C, 1 min; annealing at optimised temperatures as given
in Table 1 for 1 min; extension, 72 ◦C, 90 s) and then 72 ◦C, for 10 min. Amplimers were analysed in
1.2% agarose gel containing ethidium bromide. Actin was used as internal control. Optical density
of signals was measured by using ImageJ 1.40 g freeware and results were normalised to the optical
density of control tissue.
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Table 1. Nucleotide sequences, amplification sites, GenBank accession numbers, amplimer sizes and PCR reaction conditions for each primer pair are shown.
Gene Primer Nucleotide Sequence (5′→3′) GenBank ID Annealing Temperature Amplimer Size (bp)
Alkaline phosphatase
(Alpl)
sense GAA GTC CGT GGG CAT CGT(474–491) NM013059 59
◦C 347
antisense CAG TGC GGT TCC AGA CAT AG(801–820)
BMP2
(Bmp2)
sense AAG CCA GGT GTC TCC AAG(697–714) NM017178.1 53
◦C 209
antisense AAG TCC ACA TAC AAA GGG TG(886–905)
BMP4
(Bmp4)
sense TAG TCC CAA GCA TCA CCC(876–893) NM012827.2 53
◦C 294
antisense TCG TAC TCG TCC AGA TAC AAC(1149–1169)
BMP6
(Bmp6)
sense CCC AGA TTC CTG AGG GTG A(936–954) NM013107.1 56
◦C 248
antisense CAT GTT GTG CTG CGG TGT(1166–1183)
BMP7
(Bmp7)
sense AGG GAG TCC GAC CTC TTC T(607–625) NM001191856.1 54
◦C 297
antisense GTT CTG GCT GCG TTG TTT(886–903)
BMPR1
(Bmpr1a)
sense CCA TTG CTT TGC CAT TAT(240–257) NM009758.4 47
◦C 487
antisense TTT ACC AAC CTG CCG AAC(709–726)
Collagen type I
(Col1a1)
sense GGG CGA GTG CTG TGC TTT(348–365) NM007742.3 60
◦C 388
antisense GGG ACC CAT TGG ACC TGA A(717–735)
Int. J. Mol. Sci. 2018, 19, 2538 16 of 23
Table 1. Cont.
Gene Primer Nucleotide Sequence (5′→3′) GenBank ID Annealing Temperature Amplimer Size (bp)
CREB
(Creb1)
sense AGA TTG CCA CAT TAG CCC(95–112) NM031017.1 52
◦C 441
antisense GCT GTA TTG CTC CTC CCT(518–535)
Actin
(Actb)
sense GCC AAC CGT GAA AAG ATG A(419–437) NM007393.5 54
◦C 462
antisense CAA GAA GGA AGG CTG GAA AA(861–880)
Gli1
(Gli1)
sense
CCA CCC TAC CTC TGT CTA TTC
G
(2201–2222)
NM010296.2 49 ◦C 423
antisense CAC CCT TGT TCT GGT TTT ACC(2603–2623)
IHH
(Ihh)
sense CCA ACT ACA ATC CCG ACA TCA(248–268) NM053384.1 58
◦C 477
antisense GTC TTC ATC CCA GCC TTC C(390–408)
Osterix
(Sp7)
sense
GCC TAC TTA CCC GTC TGA CTT
T
(525–543)
NM001037632.1 56 ◦C 131
antisense GCC CAC TAT TGC CAA CTG C(634–652)
Osteocalcin
(Bglap2)
sense TAA GGT GGT GAA TAG ACT CCG(123–143) NM013414.1 56
◦C 143
antisense CCT GGA AGC CAA TGT GGT(248–265)
PAC1
(ADCYAP1R1)
sense CTA CGC CCT TTA CTA CCC AG(210–229) NM016989.2 49
◦C 247
antisense GTA TTT CTT GAC AGC CAT TTG T(435–456)
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Table 1. Cont.
Gene Primer Nucleotide Sequence (5′→3′) GenBank ID Annealing Temperature Amplimer Size (bp)
PKA
(Prkaca)
sense GCA AAG GCT ACA ACA AGG C(847–865) NM008854 53
◦C 280
antisense ATG GCA ATC CAG TCA ATC G(1109–1126)
Osteopontin
(Spp1)
sense GCT GAA GCC TGA CCC ATC T(126–144) X51834 59
◦C 494
antisense TCC CGT TGC TGT CCT GAT(602–619)
PTCH1
(Ptch1)
sense GGA ACT TAT CAC GGA GAC AG(579–578) NM053566.1 56
◦C 368
antisense AAC CTT GAC ATC CAC CAT T(928–946)
Runx2
(Runx2)
sense GGA CGA GGC AAG AGT TTC A(598–616) NM001278483.1 55
◦C 249
antisense TGG TGC AGA GTT CAG GGA G(828–846)
SHH
(Shh)
sense TCG TGC TAC GCA GTC ATC G(1042–1060) NM017221.1 56
◦C 156
antisense CCT CGC TTC CGC TAC AGA(1180–1197)
Smad1
(Smad1)
sense AGC ACC TAC CCT CAC TCC C(935–953) NM013130.2 56
◦C 306
antisense GAA ACC ATC CAC CAA CAC G(1222–1240)
VPAC1
(VIPR1)
sense GTT CTA TGG CAC GGT CAA(376–393) NM001097523 52
◦C 216
antisense AGC AAT GTT CGG GTT CTC(573–590)
VPAC2
(VIPR2)
sense TCG GAA CTA CAT CCA TCT(477–497) NM001014970 48
◦C 177
antisense TTT GCC ATA ACA CCA TAC(636–653)
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4.9. Western Blot Analysis
Tissues were cryo-grinded in liquid nitrogen. After centrifugation, tissue pellets were suspended
in 100 µL of homogenization RIPA. Samples were stored at −70 ◦C. Suspensions were sonicated by
pulsing burst for 30 s at 40 A (Cole-Parmer, Vernon Hills, IL, USA). For Western blotting, total cell
lysates were used. Samples for SDS-PAGE were prepared by the addition of Laemmli electrophoresis
sample buffer (4% SDS, 10% 2-mercaptoehtanol, 20% glycerol, 0.004% bromophenol blue, 0.125 M Tris
HCl pH 6.8) to cell lysates to set equal protein concentration of samples, and boiled for 10 min. About
40 µg of protein was separated by 7.5% SDS-PAGE gel for detection of PAC1, VPAC1, VPAC2, PKA,
ALP, osteocalcin, osteonectin, osterix, CREB, P-CREB, collagen type I, Runx2, BMP2, BMP4, BMP6,
BMP7, BMPR1, Smad1, SHH, IHH, PTCH1 and Gli1. Proteins were transferred electrophoretically
to nitrocellulose membranes. After blocking with 5% non-fat dry milk in phosphate buffered saline
(PBST) with 0.1% Tween 20, membranes were washed and exposed to the primary antibodies overnight
at 4 ◦C in the dilution as given in Table 2. After washing for 30 min in PBST, membranes were
incubated with anti-rabbit IgG (Bio-Rad Laboratories, Hercules, CA, USA) in 1:1500, anti-goat IgG
(Sigma-Aldrich) in 1:2000 and anti-mouse IgG (Bio-Rad Laboratories) in 1:1500 dilution. Signals were
detected by enhanced chemiluminescence (PierceTM) according to the instructions of the manufacturer.
Signals were developed on X-ray films and documented by gel documentary system (Fluorchem E,
ProteinSimple, Santa Clara, CA, USA). For negative or positive controls to test antibodies brain, testis
and cartilage were used from WT animals (Figures S4D, S5E and S6D). Optical density of Western
blot signals was measured by using ImageJ 1.40g freeware and results were normalised to that of
control samples.
Table 2. Tables of antibodies used in the experiments.
Antibody Host Animal Dilution Distributor
Anti-PAC1 rabbit, polyclonal, 1:600 Sigma-Aldrich, St. Louis, MO, USA
Anti-VPAC1 rabbit, polyclonal, 1:800 Alomone Labs., Jerusalem, Israel
Anti-VPAC2 rabbit, polyclonal, 1:600 Abcam, Camridge, UK
Anti-Coll. I. mouse, monoclonal, 1:1000 Sigma-Aldrich, St. Louis, MO, USA
Anti-CREB rabbit, polyclonal, 1:800 Millipore, Billerica, MA, USA
Anti-P-CREB rabbit, polyclonal, 1:800 Millipore, Billerica, MA, USA
Anti-Osterix rabbit, polyclonal, 1:200 SantaCruz Biotechnology Inc., Santa Cruz, CA, USA
Anti-Osteocalcin rabbit, polyclonal, 1:600 Abcam, Camridge, UK
Anti-Osteopontin rabbit, polyclonal, 1:500 Abcam, Camridge, UK
Anti-ALP rabbit, polyclonal, 1:500 Abcam, Camridge, UK
Anti-SHH rabbit, polyclonal, 1:600 Cell Signaling, Danvers, MA, USA
Anti-IHH rabbit, polyclonal, 1:600 Millipore, Billerica, MA, USA
Anti-PKA rabbit, polyclonal, 1:800 Cell Signaling, Danvers, MA, USA
Anti-Runx2 rabbit, polyclonal, 1:500 Cell Signaling, Danvers, MA, USA
Anti-Gli1 rabbit, polyclonal, 1:600 Cell Signaling, Danvers, MA, USA
Anti-BMP2 mouse, monoclonal, 1:500 Abcam, Camridge, UK
Anti-BMP4 rabbit, polyclonal, 1:600 Cell Signaling, Danvers, MA, USA
Anti-BMP6 rabbit, polyclonal, 1:200 SantaCruz Biotechnology Inc., Santa Cruz, CA, USA
Anti-BMP7 rabbit, polyclonal, 1:600 Abcam, Camridge, UK
Anti-BMPR1 mouse, monoclonal, 1:600 Abcam, Camridge, UK
Anti-Smad1 rabbit, polyclonal, 1:600 Cell Signaling, Danvers, MA, USA
Anti-PTCH1 rabbit, polyclonal, 1:800 Cell Signaling, Danvers, MA, USA
Anti-Actin mouse, monoclonal, 1:10,000 Sigma-Aldrich, St. Louis, MO, USA
4.10. Fracture Test
Three point bending tests were performed on mouse femurs using a Chatillon TCD225 tensile test
machine. The center part of the bones was loaded by a 5 mm diameter cylindrical head (Figure S1A).
Velocity of the head was 2 mm/min during the experiments. Value of the loading force at crack (Fm) as
well as the value of the bending deformation at crack (∆lm) were evaluated from the deformation-force
diagrams (Figure S1B).
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4.11. Statistical Analysis
All data are representative of at least three different experiments. Where applicable, data are
expressed as mean ± SEM. Statistical analysis was performed by Student’s t test. Threshold for
statistically significant differences as compared to respective control (wild type animals) was set at
* p < 0.05.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/19/9/
2538/s1.
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Abbreviations
ALP Alkaline phosphatase
BMP Bone morphogenetic protein
cAMP Cyclic adenosine monophosphate
CNS Central nervous system
CREB cAMP response element-binding protein
DMEM Dulbecco’s Modified Eagle’s Medium
dNTP deoxynucleotide triphosphate
ECM Extracellular matrix
EDTA Ethylene diamine tetra-acetic acid
EGTA Ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetra acetic acid
FBS Foetal bovine serum
FGF Fibroblast growth factor; Gli, glioma-associated oncogene
HH hedgehog
HEPES 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid
hMSC human mesenchymal stem cell
IHH Indian Hedgehog
MAPK Mitogen-activated protein kinase
PAC1 Pituitary adenylate cyclase-activating polypeptide type I receptor
PACAP Pituitary adenylate cyclase activating polypeptide, phosphate buffered saline
PBST Phosphate buffered saline supplemented with 1% Tween-20
PLC Phospholipase C
PKA Protein kinase A
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PKC Protein kinase C
PTCH Patched
RT-PCR Reverse transcription followed by polymerase chain reaction Runt-related transcription factor 2
SHH Sonic Hedgehog
TGFβ Transforming growth factor-β
VIP Vasoactive intestinal polypeptide
VPAC Vasoactive intestinal polypeptide receptor
WNT Wingless int1
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